NCT02345057

A Study to Evaluate Efficacy and Safety of CS-3150 in Japanese Type 2 Diabetic Subjects With Microalbuminuria

A Randomized, Double-blind, Placebo-controlled, Multi-center Study to Evaluate Efficacy and Safety of CS-3150 in Japanese Subjects With Type 2 Diabetes Mellitus and Microalbuminuria

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 365 (actual)
• Sponsor: Daiichi Sankyo · Industry
• Sex: All
• Age: 20 Years
• Healthy volunteers: Not accepted

Summary

This study is a randomized, placebo-controlled, double-blind, multi-center study to evaluate efficacy and safety of different doses of CS-3150 compared to placebo in Japanese Type 2 Diabetes Mellitus and Microalbuminuria. The Primary endpoint is the change from baseline in urinary albumin to creatine ratio (UACR).

Conditions

• Diabetic Nephropathy

Interventions

Type	Name	Description
DRUG	CS-3150
DRUG	placebo

Timeline

• Start date: 2015-01-01
• Primary completion: 2016-06-01
• Completion: 2016-07-01
• First posted: 2015-01-26
• Last updated: 2018-12-21

Locations

1 site across 1 country: Japan